A new analysis from The New York Times, along with German outlets NDR and WDR, took a closer look at the administration’s new drug pricing platform, TrumpRx. What they found is that while some prices have come down, Americans are still paying significantly more than patients in other wealthy countries,
Admin touts TrumpRX success: it’s a quick fix, not real progress!
Originally reported by The Hill
Related Articles
Trump says King Charles “agrees” Iran cannot have a nuclear weapon
President Trump on Tuesday said King Charles III “agrees” that Iran should not have a nuclear weapon.  “We’re...
White House Urges House to Quickly Fund D.H.S.
The call amounted to a rebuke of Speaker Mike Johnson, who has delayed action on a homeland security spending bill and s...
Full Guest List for Trump’s State Dinner With Charles and Camilla
Six members of the Supreme Court were invited to the dinner, alongside top administration officials, billionaires and Re...
More than 70 House Dems call on Trump to keep Chinese automakers out of US
More than 70 Democrats in the House signed on to a Tuesday letter urging President Trump to block Chinese automakers fro...